Postdiagnosis weight change and survival following a diagnosis of early-stage breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 1, 2017, Pages 44-50

  Feliciano, Elizabeth M Cespedes ^a   Kroenke, Candyce H ^a   Bradshaw, Patrick T ^b   Chen, Wendy Y ^c   Prado, Carla M ^d   Weltzien, Erin K ^a   Castillo, Adrienne L ^a   Caan, Bette J ^a  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BODY WEIGHT MAINTENANCE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EARLY CANCER; EARLY CANCER DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; LUMPECTOMY; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PATIENT; PRIORITY JOURNAL; VERY ELDERLY; WEIGHT CHANGE; WEIGHT GAIN; AGE; BODY MASS; BODY WEIGHT; BODY WEIGHT GAIN; BODY WEIGHT LOSS; BREAST TUMOR; CALIFORNIA; CAUSE OF DEATH; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FACTUAL DATABASE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTOR; TUMOR INVASION;

AGE FACTORS; AGED; BODY MASS INDEX; BODY WEIGHT; BREAST NEOPLASMS; CALIFORNIA; CAUSE OF DEATH; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; WEIGHT GAIN; WEIGHT LOSS;

EID: 85009127110     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0150     Document Type: Article

References (32)

1. American Cancer Society. Cancer Treatment and Survivorship Facts & Figures 2014-2015; 2014[cited 2015 Dec 23]. Available from: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042801.pdf.
2. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 2015;34:611-35.
3. NCIC Clinical Trials Group. Alliance for Clinical Trials in Oncology. MAC20 (ALLIANCE A011401) randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer; 2015. Available from: https://www.ctg.queensu. ca/public/all-disease-sites.
4. ReevesMM, Terranova CO, Eakin EG, Demark-Wahnefried W. Weight loss intervention trials in women with breast cancer: A systematic review. Obes Rev 2014;15:749-68.
5. Villarini A, Pasanisi P, Traina A, Mano MP, Bonanni B, Panico S, et al. Lifestyle and breast cancer recurrences: The DIANA-5 trial. Tumori 2012;98:1-18.
6. Bao J, Borja N, Rao M, Huth J, Leitch AM, Rivers A, et al. Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancer. Cancer Med 2015;4:500-6.
7. Bradshaw PT, Ibrahim JG, Stevens J, Cleveland R, Abrahamson PE, Satia JA, et al. Postdiagnosis change in bodyweight and survival after breast cancer diagnosis. Epidemiology 2012;23:320-7.
8. Caan BJ, KwanML, Hartzell G, Castillo A, SlatteryML, Sternfeld B, et al. Prediagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control 2008;19:1319-28.
9. Caan BJ, KwanML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, et al. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev 2012;21:1260-71.
10. Chen X, Lu W, Zheng W, Gu K, Chen Z, Zheng Y, et al. Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat 2010;122:823-33.
11. Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, et al. Body mass index before and after breast cancer diagnosis: Associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev 2009;18:1403-9.
12. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 2005;23:1370-8.
13. Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML. Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-Analysis. J Natl Cancer Inst 2015;107:djv275.
14. Thivat E, Therondel S, Lapirot O, Abrial C, Gimbergues P, Gadea E, et al. Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer 2010;10:648.
15. Cowper DC, Kubal JD, Maynard C, Hynes DM. A primer and comparative review of major US mortality databases. Ann Epidemiol 2002;12:462-8.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
17. Greenland S. Dose-response and trend analysis in epidemiology: Alternatives to categorical analysis. Epidemiology 1995;6:356-65.
18. Prat A, Cheang MCU, Martín M, Parker JS, Carrasco E, Caballero R, et al. Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer. J Clin Oncol 2013;31:203-9.
19. Goldhirsch A, Wood W, Coates A, Gelber R, Thurlimann B, Senn H-J. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011:22:1736-47.
20. Rack B, Andergassen U, Neugebauer J, Salmen J, Hepp P, Sommer H, et al. The German SUCCESS C study-The first European lifestyle study on breast cancer. Breast Care 2010;5:395-400.
21. Muss HB, Berry DA, Cirrincione C, Budman DR, Henderson IC, Citron ML, et al. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B Experience. J Clin Oncol 2007;25:3699-704.
22. Vera-Badillo FE, Al-Mubarak M, Templeton AJ, Amir E. Benefit and harms of new anti-cancer drugs. Curr Oncol Rep 2013;15:270-5.
23. Marian M. Oncology nutrition for clinical practice. In:Leser M. LN, Bergerson S, Trujillo E, editors. Energetics, exercise and cancer. Chicago, IL: Oncology Nutrition Dietetic Practice Group of the Academy of Nutrition and Dietetics; 2013. p.41-6.
24. Prado CM. Body composition in chemotherapy: The promising role of CT scans. Curr Opin Clin Nutr Metab Care 2013;16:525-33.
25. Nechuta S, Chen WY, Cai H, Poole EM, Kwan ML, Flatt SW, et al. A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor positive breast cancer prognosis. Int J Cancer 2016;138:2088-97.
26. Prado CM, Gonzalez MC, Heymsfield SB. Body composition phenotypes and obesity paradox. Curr Opin Clin Nutr Metab Care 2015; 18:535-51.
27. Villasenor A, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, McTiernan A, et al. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: The HEAL Study. J Cancer Surviv 2012;6:398-406.
28. Coughlin SS, Smith SA. The insulin-like growth factor axis, adipokines, physical activity, and obesity in relation to breast cancer incidence and recurrence. Cancer Clin Oncol 2015;4:24.
29. Goh J, Niksirat N, Campbell KL. Exercise training and immune crosstalk in breast cancer microenvironment: exploring the paradigms of exerciseinduced immune modulation and exercise-induced myokines.Am J Transl Res 2014;6:422.
30. Hauner D, Hauner H. Metabolic syndrome and breast cancer: is there a link? Breast Care 2014;9:277-81.
31. Iyengar NM, Zhou XK, Gucalp A, Morris PG, Howe LR, Giri D, et al. Systemic correlates of white adipose tissue inflammation in early-stage breast cancer. Clin Cancer Res 2016;22:2283-9.
32. Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD. Cardiovascular disease mortality among breast cancer survivors. Epidemiology 2016;27:6-13.